NEFL and Alzheimer disease: Such studies of ADAD have shown that CSF and blood NfL levels are elevated in symptomatic individuals and begin to increase 10–20 years before symptom onset (Preische et al., 2019; Sánchez-Valle et al., 2018; Weston et al., 2017), consistent with the notion that WM damage is an early event in AD.